WCN26-3194 Disulfiram, a gasdermin D inhibitor, alleviates adenine-induced renal injury in mice

Read full text Summarise with VIRAT
Authors: Saori Kin, Yuji Oe, Shun Ishigaki, Mariko Miyazaki, Tetsuhiro Tanaka
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Pyroptosis, a form of programmed inflammatory cell death mediated by caspase activation and gasdermin D (GSDMD) pore formation, has been implicated in acute kidney injury and various renal pathologies such as diabetic nephropathy and renal fibrosis. However, whether inhibition of this signaling would be beneficial in chronic kidney disease (CKD) remains unknown. Disulfiram, a clinically approved drug for alcohol dependence, has recently been identified as a potent inhibitor of GSDMD. Herein, this study aimed to investigate the therapeutic potential of disulfiram as a novel nephroprotective agent in CKD.

Fields of Study & Subjects

Inflammasome and immune disorders Acute Kidney Injury Research Chronic Kidney Disease and Diabetes

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105364–105364
Publication date
25 March 2026
Language
EN